Correction to: Cell Death and Disease https://doi.org/10.1038/s41419-022-05366-8, published online 05 November 2022
In this article the caption of Fig. 6 has been given erroneously. It should be read:
Fig. 6. Targeting ARHGEF2 reduces the tumor growth of prostate cancer cells. A Transwell migration assay in LNCaP-AI cells infected with lentiviruses carrying shARHGEF2. The left panel shows the representative microphotographs from a single independent experiment (scale bar = 100 µm). B MTT assays in LNCaP-AI cells infected with lentiviruses carrying shARHGEF2. Cell growth assessed daily for 6 days using an MTT assay in LNCaP-AI cells. Data were obtained from three independent experiments with samples in triplicate. C Transwell migration assay in 22RV1 cells infected with lentiviruses carrying shARHGEF2. The left panel shows the representative microphotographs from a single independent experiment (scale bar = 100 µm). D MTT assays in 22RV1 cells infected with lentiviruses carrying shARHGEF2. Cell growth assessed daily for 6 days using an MTT assay in 22RV1 cells. Data were obtained from three independent experiments with samples in triplicate. E, F Transwell migration assay (E) from a single independent experiment and MTT assays (F) in LNCaP cells infected with lentiviruses carrying overexpressed ARHGEF2 (oeARHGEF2) G Representative image of the dissected tumors was shown. H Growth curves of xenografts of 22RV1 cells infected with shSCR or shARHGEF2. Data are representative of mean ± SD of n = 5 tumors per group. I Representative image of the dissected tumors was shown. Representative images showing immunostaining (×100 and ×200 magnification) for ARHGEF2, FGFR1, p-ERK, SOX2, CHGA, SYN and Ki-67 in tumor specimens obtained from xenografts. For panels A, C, E two-tailed unpaired Student’s t-test; For panels B, D, F, and H, two-way ANOVA, Sidak’s multiple-comparisons test was applied. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, and ****P ≤ 0.0001.
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Chen, X., Shao, Y., Wei, W. et al. Correction: Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer. Cell Death Dis 14, 647 (2023). https://doi.org/10.1038/s41419-023-06051-0
Published:
Version of record:
DOI: https://doi.org/10.1038/s41419-023-06051-0
